Fidia Faces Governance Upheaval as Statutory Auditors Resign, Triggering Prorogatio Regime

An announcement from Fidia Spa ( (IT:FDA) ) is now available.

Fidia announced a wave of resignations affecting its control and supervisory bodies, starting with Chairman of the Board of Statutory Auditors Massimo Ceraolo, who cited a deterioration in professional relations with the administrative body and differences within the board that hindered effective oversight. The company disagreed with his characterization but formally accepted his departure and those of alternate auditors Mauro Tommasi, Federica Mascari and Stefano D’Orazio, who pointed to new professional commitments and the difficulty of guaranteeing adequate supervisory activity.

Leveraging Italian corporate law on automatic replacement and prorogatio, Fidia detailed a complex succession chain in which Tommasi and then D’Orazio were called to step up as standing auditors, with D’Orazio ultimately remaining in office under a prorogatio regime as both standing auditor and chairman until a new Board of Statutory Auditors is appointed at the shareholders’ meeting for the 2025 accounts. With no alternate auditors left, the company stressed that these resignations are unrelated to the upcoming 2025 financial statements, pledged to complete required corporate formalities, and signaled continuity of compliance oversight by temporarily assigning the chairmanship of the Supervisory Body to Daniele Catasso pending the appointment of a new body in May 2026.

The reshuffle underscores governance tensions but also the company’s reliance on statutory mechanisms to ensure continuity of its control functions, a point of interest for investors monitoring board stability and regulatory adherence. Fidia emphasized that the shareholders’ meeting will be tasked both with restoring the full composition of the Board of Statutory Auditors and appointing a new one as the current term expires, seeking to contain uncertainty while preserving oversight in a sensitive phase for its corporate governance.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading designer and manufacturer of high-performance numerical control and integrated milling systems. Its technology is used mainly for complex mold production in the automotive industry and in the aerospace sector, where the group operates as a specialized, high-end industrial supplier with about 135 employees and over 50 years of experience.

YTD Price Performance: -91.67%

Average Trading Volume: 3,437,432

Technical Sentiment Signal: Strong Sell

Current Market Cap: €682.4K

For detailed information about FDA stock, go to TipRanks’ Stock Analysis page.